Hospitalizations and hospital cost from cardiovascular diseases in Brazil

Silva, Marcela Paulino; Araújo, Anne Karoline Candido; Dantas, Dândara Nayara Azevêdo; Oliveira, Déborah Raquel Carvalho de; Silva, Richardson Augusto Rosendo da; Kluczynik, Caroline Evelin Nascimento; Enders, Bertha Cruz

doi:10.3823/2009

Cited by 4 publications

(3 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A study carried out in Brazil, the cost of hospitalizations for heart failure and myocardial infarction was estimated to be R$ 3,085.15 per patients which is lower, when compared to this study. (25) Findings of our study is similar to a study which reported a total direct cost of €3198 per patient (1 Euro = 81.69), with largest part of the expenses (79%) attributable to hospitalization (ward), while laboratory investigations and medical treatment accounted for 17% and 4%, respectively. (26)…”

Section: Discussionsupporting

confidence: 88%

Cost analysis of treating cardiovascular diseases in a super-specialty hospital

Kumar

Siddharth

et al. 2021

Preprint

View full text Add to dashboard Cite

Background Cardiovascular care is expensive; hence, economic evaluation is required to estimate resources being consumed and to ensure their optimal utilization. There is dearth of data regarding cost analysis of treating various diseases including cardiac diseases from developing countries. The study aimed to analyze resource consumption in treating cardio-vascular disease patients in a super-specialty hospital.Methods An observational and descriptive study was carried out from April 2017 to June 2018 in the Department of Cardiology, Cardio-Thoracic (CT) Centre of All India Institute of Medical Sciences, New Delhi, India. As per World Health Organization, common cardiac diseases i.e. Coronary Artery Disease (CAD), Rheumatic Heart Disease (RHD), Cardiomyopathy, Congenital heart diseases, Cardiac Arrhythmias etc. were considered for cost analysis. A total of 100 admitted patients (Ward & Cardiac Care Unit) of cardiovascular diseases were enrolled in the study using prevalence-based sampling. They were followed up till discharge. Traditional Costing and Time Driven Activity Based Costing (TDABC) methods were used for cost computation.Results Per bed per day cost incurred by the hospital for admitted patients in Cardiac Care Unit, adult and pediatric cardiology ward was calculated to be INR 28,144 (US$ 434), INR 22,210 (US$ 342) and INR 18,774 (US$ 289), respectively. Inpatient cost constituted almost 70% of the total cost and equipment cost accounted for more than 50% of the inpatient cost followed by human resource cost (28%). Per patient cost of treating any cardiovascular disease was computed to be INR 2,47,822 (US $ 3842).Conclusion Cost of treating Rheumatic Heart Disease is the highest among all CVDs followed by Cardiomyopathy and other CVDs. Cost of treating cardiovascular diseases in India is less than what has been reported in developed countries. Findings of this study would aid policy makers considering recent radical changes and massive policy reforms ushered in by the Government of India in healthcare delivery.

show abstract

Section: Discussionsupporting

confidence: 88%

Cost analysis of treating cardiovascular diseases in a super-specialty hospital

Kumar

Siddharth

et al. 2021

Preprint

View full text Add to dashboard Cite

show abstract

“…Cost of treating CVDs in developed countries appears to be much higher compared to what has been observed in this study. A study carried out in Brazil, the cost of hospitalizations for heart failure and myocardial infarction was estimated to be R$ 3,085.15 per patients which is lower, when compared to this study [ 23 ]. Findings of our study is similar to a study which reported a total direct cost of €3198 per patient (1 Euro = 81.69), with largest part of the expenses (79%) attributable to hospitalization (ward), while laboratory investigations and medical treatment accounted for 17% and 4%, respectively [ 24 ].…”

Section: Discussionmentioning

confidence: 63%

Cost analysis of treating cardiovascular diseases in a super-specialty hospital

et al. 2022

View full text Add to dashboard Cite

Cardiovascular care is expensive; hence, economic evaluation is required to estimate resources being consumed and to ensure their optimal utilization. There is dearth of data regarding cost analysis of treating various diseases including cardiac diseases from developing countries. The study aimed to analyze resource consumption in treating cardio-vascular disease patients in a super-specialty hospital. An observational and descriptive study was carried out from April 2017 to June 2018 in the Department of Cardiology, Cardio-Thoracic (CT) Centre of All India Institute of Medical Sciences, New Delhi, India. As per World Health Organization, common cardiovascular diseases i.e. Coronary Artery Disease (CAD), Rheumatic Heart Disease (RHD), Cardiomyopathy, Congenital heart diseases, Cardiac Arrhythmias etc. were considered for cost analysis. Medical records of 100 admitted patients (Ward & Cardiac Care Unit) of cardiovascular diseases were studied till discharge and number of patient records for a particular CVD was identified using prevalence-based ratio of admitted CVD patient data. Traditional Costing and Time Driven Activity Based Costing (TDABC) methods were used for cost computation. Per bed per day cost incurred by the hospital for admitted patients in Cardiac Care Unit, adult and pediatric cardiology ward was calculated to be Indian Rupee (INR) 28,144 (US$ 434), INR 22,210 (US$ 342) and INR 18,774 (US$ 289), respectively. Inpatient cost constituted almost 70% of the total cost and equipment cost accounted for more than 50% of the inpatient cost followed by human resource cost (28%). Per patient cost of treating any CVD was computed to be INR 2,47,822 (US $ 3842). Cost of treating Rheumatic Heart Disease was the highest among all CVDs followed by Cardiomyopathy and other CVDs. Cost of treating cardiovascular diseases in India is less than what has been reported in developed countries. Findings of this study would aid policy makers considering recent radical changes and massive policy reforms ushered in by the Government of India in healthcare delivery.

show abstract

“…This is particularly true for countries such as Brazil, which are transitioning from a healthcare system dominated by communicable diseases to one in which the demands of non-communicable illnesses are emerging. 14 Most previous studies that have attempted to examine the burden of disease in Brazil have been confined to individual diseases in specific regions of the country, 15 , 16 , 17 with no published data on rates of all-cause and cause-specific non-fatal health outcomes nationwide.…”

Section: Introductionmentioning

confidence: 99%

Trends in Hospital Admission Rates and Associated Direct Healthcare Costs in Brazil: A Nationwide Retrospective Study between 2000 and 2015

Zhao

Coelho

et al. 2020

The Innovation

View full text Add to dashboard Cite

Summary Background In Brazil, the increase in non-fatal events presents a new, unprecedented challenge for the free and universally accessible public healthcare system (SUS), the size and nature of which has yet to be reliably quantified. We examined the change in all-cause and cause-specific SUS hospital admissions during 2000 to 2015. Materials and Methods Data on hospital admissions across 1,816 cities were collected from the Brazilian Unified Health System. The age-standardized rates of hospital admissions, the associated healthcare costs, and length of hospital stay were quantified. Stratum analyses were performed by age, sex, region, and cause-specific categories. Results Hospital admission rates decreased by 10.2‰ per decade to 54.2‰ in 2015. For admissions in 2015, healthcare costs per patient equaled US$353 (an increase of $23.5/year since 2000) with an average length of hospital stay of 5 days (a decline of 0.04 days/year since 2000). Circulatory diseases incurred the greatest financial costs. Children and the elderly were most susceptible, especially for pneumonia. Injury and poisoning were the primary reason for admission in adult males, whereas maternal and other female-specific conditions were the highest burden in females. The burden of hospital admission was highest in the south and lowest in the north and northeast. Discussion Although hospital admission rates and length of stay have decreased in Brazil since 2000, the decline has been offset by an increase in direct healthcare costs. Age-, sex-, and region-specific features of the disease burden should be factored into future plans for healthcare expenditure in Brazil.

show abstract

Hospitalizations and hospital cost from cardiovascular diseases in Brazil

Cited by 4 publications

References 2 publications

Cost analysis of treating cardiovascular diseases in a super-specialty hospital

Cost analysis of treating cardiovascular diseases in a super-specialty hospital

Cost analysis of treating cardiovascular diseases in a super-specialty hospital

Trends in Hospital Admission Rates and Associated Direct Healthcare Costs in Brazil: A Nationwide Retrospective Study between 2000 and 2015

Contact Info

Product

Resources

About